Soft Tissue Regeneration, Inc.
Joseph W. Reilly, President & CEO

Soft Tissue Regeneration, Inc. is a privately held medical device company defining new technology for the soft tissue regeneration segment of the sports medicine market. The Company has developed and tested a breakthrough biodegradable scaffold for regeneration of the anterior cruciate ligament (ACL) of the knee and for the first time, has regenerated a native, natural ACL, capable of carrying normal load,  after full resorption of the scaffold.  The Company is also developing an augmentation device for rotator cuff repair.